$96.57-0.44 (-0.45%)
Itron, Inc., a technology, solutions, and service company, provides end-to-end solutions that help manage energy, water, and smart city operations worldwide.
Itron, Inc. in the Technology sector is trading at $96.57 with a market capitalization of $4.4B. Wall Street consensus targets $129.60 (10 analysts), implying a +34.2% move over the next 12 months. The stock is currently 32% below its 52-week high of $142.00, remaining 4.6% above its 200-day moving average. On fundamentals, Piotroski 7/9 indicates strong financial quality. The Whystock Score of 100/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | — | $586.98M↑ | $571.66M↓ | $581.63M↓ | $606.76M |
| Gross Profit | — | $236.32M↑ | $231.74M↑ | $219.54M↓ | $223.62M |
| Operating Income | — | $67.79M↓ | $78.72M↓ | $81.97M↑ | $77.65M |
| Net Income | — | $53.46M↓ | $101.63M↑ | $65.61M↓ | $68.34M |
Itron, Inc., a technology, solutions, and service company, provides end-to-end solutions that help manage energy, water, and smart city operations worldwide. It operates in four segments: Device Solutions, Networked Solutions, Outcomes, and Resilienc...

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Even if a company is profitable, it doesn’t always mean it’s a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest wisely, limiting their future potential.

Looking back on inspection instruments stocks’ Q2 earnings, we examine this quarter’s best and worst performers, including Itron (NASDAQ:ITRI) and its peers.

Itron (ITRI) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

The average brokerage recommendation (ABR) for Itron (ITRI) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?